Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Nutriband Inc. - Common Stock
(NQ:
NTRB
)
4.460
+0.050 (+1.14%)
Streaming Delayed Price
Updated: 10:15 AM EST, Jan 7, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Nutriband Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
...
11
12
Next >
Abuse Deterrent Formulations Market Exploding While Estimated to Reach $39 Million In 2025 and $54 Million By 2030
June 18, 2025
EQNX::TICKER_START (NASDAQ:NTRB),(NASDAQ:NTRBW),(NYSE:PFE),(NASDAQ:COLL),(NYSE:TEVA),(NYSE:EBS) EQNX::TICKER_END
Via
FinancialNewsMedia
Topics
Death
NUTRIBAND AND KINDEVA COMPLETE COMMERCIAL MANUFACTURING PROCESS SCALE-UP FOR AVERSA™ FENTANYL ABUSE DETERRENT FENTANYL PATCH
June 18, 2025
Nutriband and Kindeva have completed commercial manufacturing process scale-up for its lead product Aversa™ Fentanyl, an abuse-deterrent fentanyl patch. Nutriband is partnering with Kindeva to develop...
Via
FinancialNewsMedia
Abuse Deterrent Formulations Market Exploding While Estimated to Reach $39 Million In 2025 and $54 Million By 2030
June 18, 2025
From
FN Media Group LLC
Via
GlobeNewswire
Nutriband and Kindeva Complete Commercial Manufacturing Process Scale-up for Aversa™ Fentanyl Abuse Deterrent Fentanyl Patch
June 18, 2025
From
Nutriband Inc.
Via
GlobeNewswire
Nutriband Inc. (NASDAQ: NTRB) Reports Double-Digit Revenue Increase, Continued Progress on AVERSA Fentanyl Development
June 12, 2025
Via
Investor Brand Network
Topics
Intellectual Property
BioMedNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) Secures U.S. Patent for Abuse-Deterrent Transdermal Technology
June 09, 2025
Via
Investor Brand Network
Topics
Intellectual Property
Nutriband Announces U.S. Patent Issued for Its Transdermal Abuse Deterrent Technology
June 09, 2025
From
Nutriband Inc.
Via
GlobeNewswire
Nutriband Inc. (NASDAQ: NTRB) Advances Abuse-Deterrent Buprenorphine Therapy with AVERSA Technology
June 05, 2025
Via
Investor Brand Network
Nutriband Inc. (NASDAQ: NTRB): A Relentless Mission Rooted in Purpose, Innovation, and Shareholder Value
June 04, 2025
Via
Investor Brand Network
Topics
Initial Public Offering
BioMedNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) to Present at Noble Capital Markets Emerging Growth Virtual Conference
June 03, 2025
Via
Investor Brand Network
Nutriband Inc. to present at the 2025 Noble Capital Markets Virtual Equity Conference
June 03, 2025
From
Nutriband Inc.
Via
GlobeNewswire
BioMedNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) Posts Record Q1 Revenue, Advances AVERSA Fentanyl Development
June 02, 2025
Via
Investor Brand Network
Nutriband Inc. Quarterly Report Highlights Record Revenue for Q1, 2025 up 63% YOY and Strategic Progress Toward NDA Filing for AVERSA Fentanyl
June 02, 2025
From
Nutriband Inc.
Via
GlobeNewswire
BioMedNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) CEO Highlights Transdermal Pain Solution on BioMedWire Podcast
May 27, 2025
Via
Investor Brand Network
Nutriband Inc. (NASDAQ: NTRB) Charts Path to Commercialization
May 22, 2025
Via
Investor Brand Network
BioMedNewsBreaks — Nutriband Inc. (NASDAQ: NTRB) Strengthens Pharma Footprint Through Key Alliances
May 15, 2025
Via
Investor Brand Network
Topics
Artificial Intelligence
Nutriband Inc. (NASDAQ: NTRB) Pioneers Innovative Approach to Opioid Crisis with Game-Changing Transdermal Patch
May 13, 2025
Via
Investor Brand Network
Nutriband Inc. (NASDAQ: NTRB) Innovating Abuse-Deterrent Drug Delivery in a Shifting Opioid Landscape
May 09, 2025
Via
Investor Brand Network
12 Health Care Stocks Moving In Wednesday's Intraday Session
↗
April 30, 2025
Via
Benzinga
BioMedNewsBreaks — Nutriband Inc. (NASDAQ: NTRB) CEO Issues Shareholder Letter Highlighting 2024 Milestones and 2025 Commercialization Goals
April 30, 2025
Via
Investor Brand Network
Topics
Intellectual Property
Nutriband Inc. (NASDAQ: NTRB) Leadership Team: Driving Innovation and Shaping the Future of Global Healthcare
April 30, 2025
Via
Investor Brand Network
Nutriband CEO Publishes Letter to Shareholders
April 30, 2025
From
Nutriband Inc.
Via
GlobeNewswire
Nutriband Inc. (NASDAQ: NTRB) Solution To Fentanyl Abuse Could Translate To $200 Million In Peak Revenue
April 30, 2025
Via
AB Newswire
Topics
Intellectual Property
Nutriband Inc (NASDAQ: NTRB) Solution To Fentanyl Abuse Could Translate To $200 Million In Peak Revenue
April 30, 2025
Nutriband Inc (NASDAQ: NTRB) Solution To Fentanyl Abuse Could Translate To $200 Million In Peak Revenue
Via
News Direct
Topics
Intellectual Property
BioMedNewsBreaks — Why Nutriband Inc. (NASDAQ: NTRB) Is ‘One to Watch’
April 25, 2025
Via
Investor Brand Network
Topics
Intellectual Property
Nutriband Inc. (NASDAQ: NTRB): Building a Moat Around Abuse-Deterrent Drug Delivery
April 22, 2025
Via
Investor Brand Network
Topics
Intellectual Property
BioMedNewsBreaks — Nutriband Inc. (NASDAQ: NTRB) CEO Named EY Entrepreneur of the Year 2025 Finalist in Established Category
April 17, 2025
Via
Investor Brand Network
InvestorNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) Secures Patent in Macao for AVERSA Abuse-Deterrent Technology
April 11, 2025
Via
Investor Brand Network
Topics
Intellectual Property
Nutriband Granted Patent in Macao for its AVERSA Abuse Deterrent Transdermal Technology
April 11, 2025
Nutriband granted patent protecting its AVERSA abuse deterrent platform technology in Macao, a Special Administrative Region of the People’s Republic of China
From
Nutriband Inc.
Via
GlobeNewswire
UPDATE – Nutriband Signs Associate Partnership with Charlotte FC
April 04, 2025
From
Nutriband Inc.
Via
GlobeNewswire
< Previous
1
2
3
4
5
6
7
8
9
...
11
12
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
